Guide for patients & caregivers

Interstitial Lung Abnormalities (ILA) Found on CT: What Happens Next?

Interstitial lung abnormalities (ILA) on CT explained: why the incidental finding matters, usual follow-up, smoking, and when lung fibrosis is considered.

By SameCase EditorialUpdated 6 min read

Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles

What are interstitial lung abnormalities on a CT scan?

Interstitial lung abnormalities (ILA) are changes seen on a CT scan that could fit with interstitial lung disease (ILD) in someone who was not suspected of having it. They are usually found by chance on a scan done for another reason, such as lung cancer screening or a heart or abdominal CT. ILA is a description of what the scan shows, not a diagnosis.

The 2025 American Thoracic Society (ATS) clinical statement defines ILA as non-dependent changes in both lungs, such as ground-glass opacity, reticulation (a fine net-like pattern), lung distortion, traction bronchiectasis or honeycombing, affecting at least 5% of a lung zone. This guide explains what usually happens after the finding. It cannot say whether a particular scan shows early disease.

Symptoms that need urgent care

An incidental CT finding can usually be discussed at a planned appointment. New or severe symptoms cannot wait for that. The NHS advises calling the emergency number or going to an emergency department for severe difficulty breathing, a chest that feels tight or heavy, lips or skin turning blue or grey, or sudden confusion.

The NHS advises seeing a GP if breathlessness is getting worse during normal activities or when lying down, or if a cough has lasted three weeks or more. Mention the ILA report when you do.

How common is ILA, and who gets it?

The Fleischner Society position paper describes ILA as a common finding on CT in older adults, reported in 4% to 9% of smokers and 2% to 7% of non-smokers in the study groups it reviewed. Finding it more often is partly a result of more people having CT scans.

Risk factors described by the Fleischner and ATS documents include older age and smoking, with some studies also linking ILA to male sex, occupational and air-pollution exposures, and a genetic variant called MUC5B. The ATS statement also lists family history of pulmonary fibrosis and connective tissue disease among higher-risk features.

Is ILA the same as pulmonary fibrosis or ILD?

No. ILA describes a scan appearance in someone without suspected disease. ILD is a clinical diagnosis. The ATS statement says ILD is distinguished from ILA by symptoms such as breathlessness or cough caused by the lung changes, abnormal or declining lung function, fibrotic or progressive changes on imaging, or specific fibrotic patterns on imaging or biopsy.

The Fleischner paper groups ILA into non-subpleural, subpleural non-fibrotic and subpleural fibrotic types. It says the subpleural fibrotic type is more likely to progress and is linked with higher mortality, while non-subpleural ILA seldom progresses. For background on scarring that is not ILA, such as a small scar after infection, see the guide on lung scarring on CT. For a hazy patch or a ground-glass nodule on its own, see the ground-glass opacity guide.

What follow-up is usual after ILA is found?

The ATS statement suggests a baseline check of symptoms (cough and breathlessness on exertion) and baseline lung function tests, including how well the lungs transfer oxygen. It suggests a follow-up chest CT 2 to 3 years after the first scan, with earlier review for people with higher-risk features or new symptoms. It says patients with any concerning features should be referred to a lung specialist.

The Fleischner paper suggests that people with risk factors for progression may be reviewed sooner, and that people without risk factors should be told to come back if symptoms develop. Both documents say the best follow-up interval is still uncertain, so plans differ between services.

The ATS statement suggests against routine lung biopsy, MUC5B gene testing or telomere length testing just because ILA has been found. Those tests may still be used in specific situations, for example when ILD criteria are met.

Will ILA get worse?

Some ILAs stay the same and some progress. The Fleischner paper estimates that about 20% progress over 2 years and more than 40% over 5 years in the studies it reviewed. Progression on a scan does not always mean symptoms, and the figures come from research groups, so they cannot predict what will happen to one person.

Fibrotic features, subpleural location, smoking and borderline lung function are among the factors linked to a higher chance of progression. The Fleischner paper also notes that people with ILA may have a higher risk of lung complications from some cancer treatments and surgery, which is worth telling any team planning those treatments.

Does smoking matter if ILA is found?

Yes. Smoking is linked to ILA in nearly all populations studied, according to the Fleischner paper. The ATS statement recommends harm reduction during follow-up, including stopping smoking, reducing or avoiding harmful inhaled exposures at work or home, and age-appropriate vaccination.

NHLBI lists smoking, older age and family history as risk factors for idiopathic pulmonary fibrosis, and the NHS notes links with long-term exposure to some dusts such as metal, wood or asbestos. Local stop-smoking services can offer support.

Questions to ask your clinician

Bring the full CT report, the reason the scan was done, any older chest imaging, and a list of medicines, work or hobby exposures and family history of lung disease.

  • Which type of ILA does the report describe, and are there fibrotic features?
  • Do I have any symptoms or test results that would make this ILD rather than ILA?
  • Will I have lung function tests, and who will review them?
  • When is my next CT, and who is responsible for booking it?
  • Should I see a lung specialist, and which new symptoms should make me get in touch sooner?
  • Does this finding matter for any surgery or cancer treatment I am planning?

How comparing similar cases on SameCase can help

On SameCase, patients and verified doctors share de-identified cases. Reading how others with ILA on a CT report described the wording, their symptoms and the follow-up they were offered can help you spot details to check and write clearer questions for your own appointment.

Other people's cases cannot show whether your ILA will change or what your scan means. Your own clinician, who can see the images and your history, makes that judgement.

Sources and further reading

For patients & caregivers

Share your case and learn from others

Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.

Keep learning